{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:22:31Z","timestamp":1793881351046,"version":"4.7.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","prd-journal.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.parkreldis.2017.02.007","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T13:17:53Z","timestamp":1486473473000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test"],"prefix":"10.1016","volume":"39","author":[{"given":"Margherita","family":"Fabbri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonor Correia","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Chendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario M.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilza","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Godinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim J.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.parkreldis.2017.02.007_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1590\/0004-282X20150029","article-title":"Non-motor signs in Parkinson's disease: a review","volume":"73","author":"Munhoz","year":"2015","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.parkreldis.2017.02.007_bib2","first-page":"1759","author":"Coelho","year":"2012","journal-title":"Late-stage Park. Dis."},{"key":"10.1016\/j.parkreldis.2017.02.007_bib3","series-title":"Sydney Multicenter Study of Parkinson's Disease: Non-L-dopa-responsive Problems Dominate at 15 Years","first-page":"0885","author":"Hely","year":"2005"},{"issue":"9","key":"10.1016\/j.parkreldis.2017.02.007_bib4","first-page":"1524","article-title":"Late-stage Parkinson's disease: the Barcelona and Lisbon cohort","volume":"257","author":"Coelho","year":"2010","journal-title":"J.\u00a0Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.007_bib5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","article-title":"Non-recognition of depression and other non-motor symptoms in Parkinson's disease","volume":"8","author":"Shulman","year":"2002","journal-title":"Park. Relat. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2017.02.007_bib6","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/jgs.12458","article-title":"Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life","volume":"61","author":"Weerkamp","year":"2013","journal-title":"J.\u00a0Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.007_bib7","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.59.3.408","article-title":"Nonmotor fluctuations in Parkinson's disease: frequent and disabling","volume":"59","author":"Witjas","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2017.02.007_bib8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1002\/mds.26415","article-title":"New clinical trials for nonmotor manifestations of Parkinson's disease","volume":"30","author":"Schrag","year":"2015","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2017.02.007_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1517\/14656566.9.4.523","article-title":"Treatment options for non-motor symptoms in late-stage Parkinson's disease","volume":"9","author":"Coelho","year":"2008","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.parkreldis.2017.02.007_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2016.02.021","article-title":"Do patients with late-stage Parkinson's disease still respond to levodopa?","volume":"26","author":"Fabbri","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.007_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatr."},{"issue":"15","key":"10.1016\/j.parkreldis.2017.02.007_bib12","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.007_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/mds.21198","article-title":"Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan","volume":"22","author":"Goetz","year":"2007","journal-title":"Mov. Disord."},{"issue":"13","key":"10.1016\/j.parkreldis.2017.02.007_bib14","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/mds.21596","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study","volume":"22","author":"Chaudhuri","year":"2007","journal-title":"Mov. Disord."},{"issue":"5 Suppl 6","key":"10.1016\/j.parkreldis.2017.02.007_bib15","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","article-title":"The Neuropsychiatric Inventory: assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2017.02.007_bib16","first-page":"165","article-title":"Geriatric Depression Scale (GDS): recent evidence and development of a shorter version","author":"Sheikh JI","year":"1986","journal-title":"Clin. Gerontol. A Guide Assess. Interv."},{"issue":"16","key":"10.1016\/j.parkreldis.2017.02.007_bib17","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/mds.21844","article-title":"Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2017.02.007_bib18","series-title":"Manual for the State-Trait Anxiety Inventory","author":"Spielberger","year":"1983"},{"key":"10.1016\/j.parkreldis.2017.02.007_bib19","series-title":"The Sydney Multicenter Study of Parkinson's Disease: the Inevitability of Dementia at 20 Years","author":"Hely","year":"2008"},{"issue":"14","key":"10.1016\/j.parkreldis.2017.02.007_bib20","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/mds.25678","article-title":"The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study","volume":"28","author":"Youssov","year":"2013","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2017.02.007_bib21","first-page":"63","article-title":"Pain in Parkinson's disease","volume":"5","author":"Ford","year":"1998","journal-title":"Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.parkreldis.2017.02.007_bib22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/mds.22546","article-title":"Pain intensity on and off levodopa in patients with Parkinson's disease","volume":"24","author":"Nebe","year":"2009","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2017.02.007_bib23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.wnl.0000324862.29733.69","article-title":"Fatigue in levodopa-naive subjects with Parkinson disease","volume":"71","author":"Schifitto","year":"2008","journal-title":"Neurology"},{"issue":"13","key":"10.1016\/j.parkreldis.2017.02.007_bib24","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/mds.26030","article-title":"Interventions for fatigue in Parkinson's disease: a systematic review and meta-analysis","volume":"29","author":"Franssen","year":"2014","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.007_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/mds.21205","article-title":"Acute effects of immediate and controlled-release levodopa on mood in Parkinson's disease: a double-blind study","volume":"22","author":"Kulisevsky","year":"2007","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.parkreldis.2017.02.007_bib26","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/WNL.45.9.1757","article-title":"Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study","volume":"45","author":"Maricle","year":"1995","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.007_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","article-title":"Anxiety in Parkinson's disease: a critical review of experimental and clinical studies","volume":"62","author":"Prediger","year":"2012","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.parkreldis.2017.02.007_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.parkreldis.2017.02.007_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000348350","article-title":"Cognitive profiles of patients with mild cognitive impairment or dementia in Alzheimer's or Parkinson's disease","volume":"3","author":"Hildebrandt","year":"2013","journal-title":"Dement. Geriatr. Cognit. Disord. Extra"},{"issue":"7","key":"10.1016\/j.parkreldis.2017.02.007_bib30","first-page":"1073","article-title":"Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease","volume":"257","author":"Riedel","year":"2010","journal-title":"J.\u00a0Neurol."},{"issue":"5\u20136","key":"10.1016\/j.parkreldis.2017.02.007_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000442151","article-title":"Levodopa-Carbidopa intestinal gel infusion therapy in advanced Parkinson's disease: single middle Eastern center experience","volume":"74","author":"Bohlega","year":"2015","journal-title":"Eur. Neurol."},{"issue":"3","key":"10.1016\/j.parkreldis.2017.02.007_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.parkreldis.2014.12.012","article-title":"Global long-term study on motor and non-motor symptoms and safety of levodopa-carbidopa intestinal gel in routine care of advanced Parkinson's disease patients; 12-month interim outcomes","volume":"21","author":"Antonini","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2017.02.007_bib33","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.parkreldis.2015.05.014","article-title":"Long-term response to continuous duodenal infusion of levodopa\/carbidopa gel in patients with advanced Parkinson disease: the Barcelona registry","volume":"21","author":"Buongiorno","year":"2015","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.parkreldis.2017.02.007_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s40263-016-0336-5","article-title":"Levodopa-Carbidopa intestinal gel in patients with Parkinson's disease: a systematic review","volume":"30","author":"Wirdefeldt","year":"2016","journal-title":"CNS drugs"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201730041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135380201730041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T09:24:15Z","timestamp":1536053055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135380201730041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":34,"alternative-id":["S135380201730041X"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.007","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}